Literature DB >> 2820844

The use of a selectable FokI cassette in DNA replacement mutagenesis of the R388 dihydrofolate reductase gene.

P S Vermersch1, G N Bennett.   

Abstract

FokI, a class-IIS restriction endonuclease, cleaves double-stranded DNA to produce a protruding 5' end consisting of four nucleotides, 10-13 residues 3' from the nonpalindromic recognition sequence, GGATG. Cassettes which utilize this separation of cleavage and recognition site have been constructed for the purpose of linker mutagenesis and DNA replacement experiments. The cassettes are flanked by FokI recognition sequences oriented such that the FokI cleavage sites are several nucleotides beyond the cassette/vector fusion sites. FokI excises the cassette and several base pairs of the neighboring vector sequence. The ends produced in the vector by FokI cleavage are generally noncomplementary and suitable for the insertion of a segment of synthesized double-stranded replacement DNA. A cassette which contains a tyrosine tRNA suppressor gene (supF) is selectable by the suppression of amber mutations in the recipient host. A vector containing a pBR322-derived origin of replication, the Escherichia coli xanthine-guanine phosphoribosyl transferase gene as a selectable marker, and no FokI sites has been constructed for use with the FokI cassettes. An experiment which utilized the FokI/supF cassette to modify the N-terminal coding region of the R388 dihydrofolate reductase gene is described.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820844     DOI: 10.1016/0378-1119(87)90491-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  BcefI, a new type IIS restriction endonuclease.

Authors:  P Venetianer; A Orosz
Journal:  Nucleic Acids Res       Date:  1988-04-11       Impact factor: 16.971

2.  Overproduction and crystallization of FokI restriction endonuclease.

Authors:  K Kita; H Kotani; N Hiraoka; T Nakamura; K Yonaha
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.